General Information
Revision date
2019-07-01
Product name
Lenvatinib, Free Base
CAS No.
417716-92-8
Icons in SDS
Company Information
company name
LC Laboratories
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H302+H312+H332
Hazard statements
Code
Statements
H302+H312+H332
Harmful if swallowed, in contact with skin or if inhaled
Section 2
Hazard statements
pharmaceutically active substance that has not been fully tested May be harmful if swallowed, inhaled, or absorbed through the skin Ingestion may result in fatigue, myalgia (muscle pain), arthralgia (joint pain), anorexia (decreased appetite)/weight loss, headache, nausea, vomiting, diarrhea, abdominal pain, stomatitis (mouth sores), renal impairment/proteinuria (protein in the urine), increased liver enzymes (ALT/AST), palmar-plantar erythrodysesthesia (also known as hand-foot syndrome manifested as redness, tenderness, peeling, blistering and ulceration of the palms and soles), cardiac dysfunction/prolonged QT/QTc interval (heart rhythm disorder), arterial thromboembolic events (blood clots), hypertension (high blood pressure), and dysphonia (difficulty speaking) May cause embryo-fetal harm Exposure may cause irritation of the skin, eyes, mucous membranes, and upper respiratory tract H302+312+332 - Harmful if swallowed, in contact with skin or if inhaled
Precautionary statements
P2562 - Do not get in eyes, on skin or on clothing WARNING For Laboratory Research Use Only
